The purpose of clinical work is to provide care which is appropriate to the needs of patients. Care is appropriate when the benefits to the patient outweigh the risks by such a degree as to make it worth giving. In the clinical setting, a guideline is a statement which describes appropriate care, and signals clinical actions which have an established link to a desired health outcome.
In developing such guidelines a number of issues must be considered. First, decisions about appropriateness must take account of different viewpoints. For instance, a practitioner requires evidence of the clinical effectiveness of a procedure, and a purchaser also needs evidence of its cost-effectiveness, and patients want to know their chances of 'feeling better' when it is completed. Better information is being called for, to inform the decisions of all those affected by health care.
Secondly, the appropriateness of care is not absolute, but changes with advancing knowledge. Few would now defend the use of barbiturates, or long-term benzodiazepines in the treatment of symptoms of anxiety and depression, or the use of insulin-induced coma for the treatment of a patient suffering from mental illness. New approaches are introduced because they are thought to have the potential to improve patient care. They are systematically evaluated in research and practice settings, and abandoned if it becomes apparent that their benefits do not outweigh the risks. Psychiatry, like all fields of medicine, is scattered with examples of treatment that have gone out of fashion.
Finally, clinical decision-making is a complex process, focusing on the individual needs of patients; for example, consider the clinical decisions involved in choosing a suitable management for a patient with schizophrenia who continues to hear frightening auditory hallucinations, despite an adequate trial of antipsychotic medication. The clinician may consider a social, pharmacological or psychological intervention, or combination of these in further management. The patient's preferences, together with those of the carers will be influential. If a pharmacological approach is appropriate, the patient's age, current health, past medical history, and immediate risk will influence the clinician's choice of the most suitable preparation from a range of anti-psychotic drugs and a safe, but effective dose range. For instance, the risks and benefits of using an atypical neuroleptic such as clozapine, will include evidence of its clinical effectiveness, as well as its resource implications, including assessment and monitoring procedures, compared against the same evidence associated with more traditional preparations. He or she will consider the availability of the necessary clinical skills and the competing needs of other patients. Social and psychological treatments will be appraised in the same way.
Given this complexity, it comes as little surprise that variation is found whenever patterns of care are compared across co-ordinates the work of individual work groups. Each CPG will be developed by a separate work group following a project plan agreed with the steering group. While limiting the size of the work groups, their composition will reflect the interests of those affected by the guideline, and ensure the process involves all relevant clinical disciplines, users, carers and their advocates, and purchaser and provider managers where appropriate. A full-time facilitator will support the Programme's work.
The Programme will address each of the following stages in CPG development and implementation (Marriott & Lelliott, 1994) . Although described sequentially, the work of different stages will proceed simultaneously.
Setting priorities across the mental health community
An important first step for guideline developers is the fomulation of sensible priorities. The College Steering Group has recently consulted across the mental health community, commissioning a large national survey including psychiatric audit convenors, representatives from each of the professions involved in mental health, consultant and trainee psychiatrists from all the specialities, service users and their representatives, and provider groups. Preliminary findings suggest considerable agreement among them on priorities, and the full findings will be published soon. Clinical issues arising in the assessment and management of high risk behaviour will feature strongly in the first College CPG.
Critical review of the scientific evidence
The soundness and relevance of the scientific evidence relating to a topic must be evaluated and weighted. This evidence may include studies of different design and detail, both published and unpublished literature, and of varying degrees of rigour.
The College Programme will use a systematic approach to identify relevant literature, and grade it according to the study design it is derived from. Randomised controlled trials are the most powerful research design, but where they are not available there are strong arguments for the value of results from studies with less powerful designs.
The end products of this stage are provisional recommendations based solely on the research evidence. 
Clinical and non-clinical modulating factors

Appraisal, review and revision
Guidelines should be subject to external peer review to appraise the validity of their development and content. A number of tools have been developed to rate the important attributes of CPGs, including validity, reliability, and clarity. Only well-designed pilot trials can establish a CPG's clinical effectiveness.
The CPG products
Most guideline developers have chosen to design sets of guidelines, which provide a comprehensive overview of a clinical problem. For instance, the 1993 AHCPR guideline Depression in Primary Care: Detection, Diagnosis, and Treatment includes more than a hundred guideline statements, supported by 3,500 references. The parent product of CPG development can be large, and complex. This is called the Guideline Report.
Later products may have a variety of purposes, and may be presented as: a clinical tool -to support and inform clinical decisions; an audit tool -to yield valid, reliable, routinely collected data; an educational tool -to promote understanding; or a combination of these. The end products of a CPG can be presented in a wide variety of formats including structured medical records, pocket books summarising guidelines, computer help screens, and text books. Audit tools support the collection of measurement Information by including clinical review criteria and clinical indicators. Educational tools may be targeted
Clinical practice guidelines at a range of professional users, as well as presented as patient information.
Getting guidelines into practice
The main measure ofsuccess ofa guideline is the extent to which it results in improved patient care in routine practice. To achieve this aim, clinicians must be aware of it, accept it and use it. Educational strategies are important in influencing clinicians' awareness, but are not necessarily sufficient to change clinical practice.
Barriers to implementing externally developed guidelines are often subtle, and can include an undermining of the sense of ownership among those who implement initiatives. Non clinical supports, such as information management systems, may also have a practical role to play in promoting, or hindering change. Patient specific reminders available at, or near to, the consultation appear to help clinicians to use guidelines. When guidelines are set out as broad statements of principle their operational detail can be developed by the clinicians who implement them, in accordance with local circumstance and need. Carefully implemented guidelines can change clinical practice, but more evidence is needed to understand their impact on health outcomes (EffectiveHealth Care, 1994 (Feder, 1994) . The clinical professions are in the strongest position to undertake their development, and guide this evaluation. The Royal College of Psychiatrists' first CPG will be available towards the end of next year. 
